Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

324
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
324
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

201
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
201
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

421
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
421
Phosphate Buffer01:22

Phosphate Buffer

3.9K
The phosphate buffer system is a critical biological mechanism for maintaining pH stability in the body. This system operates primarily through two components: sodium dihydrogen phosphate (NaH2PO4), which acts as a weak acid, and sodium hydrogen phosphate (Na2HPO4), which serves as a weak base.
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
3.9K
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

874
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
874
Dialysis01:15

Dialysis

1.2K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How are developments in the treatment armamentarium of hyperphosphatemia addressing the current therapeutic challenges?

Expert opinion on pharmacotherapy·2026
Same author

AlmaSDG: A Dataset of Scientific Articles' Contributions to the UN Sustainable Development Goals.

Scientific data·2026
Same author

Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases.

Clinical kidney journal·2026
Same author

Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair.

Journal of the American Society of Nephrology : JASN·2026
Same author

Uremic Toxin-Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes.

Toxins·2026

Related Experiment Video

Updated: Nov 16, 2025

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
08:21

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method

Published on: May 18, 2018

14.9K

Do we need new phosphate binders in dialysis?

Mario Cozzolino1, Andrea Galassi1, Paola Ciceri2

  • 1Renal Division, ASST Santi Paolo e Carlo, Depart. of Health Sciences, University of Milan, Milan, Italy.

Clinical Kidney Journal
|February 24, 2021
PubMed
Summary
This summary is machine-generated.

Patients with chronic kidney disease (CKD) face higher mortality risks, primarily from cardiovascular events. Phosphate binders are crucial for managing hyperphosphataemia in dialysis patients, showing reduced mortality regardless of binder type.

Keywords:
CKD-MBDdialysishyperphosphataemiaphosphate binder

More Related Videos

Synthesis of High Purity Nonsymmetric Dialkylphosphinic Acid Extractants
12:06

Synthesis of High Purity Nonsymmetric Dialkylphosphinic Acid Extractants

Published on: October 19, 2017

7.7K
Separation of Single-stranded DNA, Double-stranded DNA and RNA from an Environmental Viral Community Using Hydroxyapatite Chromatography
13:46

Separation of Single-stranded DNA, Double-stranded DNA and RNA from an Environmental Viral Community Using Hydroxyapatite Chromatography

Published on: September 29, 2011

32.1K

Related Experiment Videos

Last Updated: Nov 16, 2025

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
08:21

Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method

Published on: May 18, 2018

14.9K
Synthesis of High Purity Nonsymmetric Dialkylphosphinic Acid Extractants
12:06

Synthesis of High Purity Nonsymmetric Dialkylphosphinic Acid Extractants

Published on: October 19, 2017

7.7K
Separation of Single-stranded DNA, Double-stranded DNA and RNA from an Environmental Viral Community Using Hydroxyapatite Chromatography
13:46

Separation of Single-stranded DNA, Double-stranded DNA and RNA from an Environmental Viral Community Using Hydroxyapatite Chromatography

Published on: September 29, 2011

32.1K

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Mineral Metabolism

Background:

  • Chronic kidney disease (CKD) patients exhibit increased mortality risk compared to the general population.
  • Cardiovascular events are the leading cause of death in CKD patients, particularly in advanced stages.
  • Disrupted mineral metabolism and hyperphosphataemia are key contributors to vascular complications in CKD.

Discussion:

  • Phosphate binders are a standard therapeutic approach for managing hyperphosphataemia in dialysis patients.
  • Studies indicate that phosphate binder use is associated with a reduced risk of mortality in dialysis patients.
  • This mortality benefit appears to be independent of the specific class of phosphate binder administered.

Key Insights:

  • Hyperphosphataemia and mineral metabolism derangements are critical in CKD-related cardiovascular mortality.
  • Phosphate binders effectively mitigate hyperphosphataemia in dialysis patients.
  • Treatment with phosphate binders correlates with improved survival outcomes in dialysis populations.

Outlook:

  • Further research into optimizing phosphate binder therapy for CKD patients.
  • Investigating the precise mechanisms linking phosphate binders to cardiovascular risk reduction.
  • Exploring novel strategies for mineral metabolism management in chronic kidney disease.